Viewing nowCombinationAprovasc Tablets 150/10 mg (Irbesartan, Amlodipine Besilate)
Irbesartan 150mg · Amlodipine Besylate 14mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.

MFDS item code 202303234 · Approved 2023.11.28 · Insurance code 652105920
Treatment of essential hypertension not controlled by irbesartan monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by Irbesartan monotherapy.
○ Adults Take 1 tablet once daily with water, with or without food. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of irbesartan be adjusted. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. • 150/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy. • 150/10 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy or this medicine at 150/5 mg. • 300/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 300 mg monotherapy. Patients taking irbesartan and amlodipine as separate medicines may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. In general, blood pressure control over 24 hours is better with irbesartan 150 mg than with irbesartan 75 mg once daily. However, irbesartan 75 mg may be considered in certain cases (such as at the start of treatment, in patients on hemodialysis, or in patients aged 75 years and older). This medicine is not recommended when a reduction in the irbesartan dose (e.g., to 75 mg once daily) is required. ○ Older adults Dose adjustment is generally not necessary. However, in patients aged 75 years and older, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with renal impairment Dose adjustment is generally not necessary. However, in patients on hemodialysis, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended that the daily dose of irbesartan not exceed 150 mg. However, there is no clinical experience with irbesartan in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus if administered to pregnant women; therefore, use should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to patients with specific allergic reactions, severely impaired liver function, history of angioedema, severe kidney problems, or diabetic nephropathy. Elderly patients or those with high serum potassium levels, mildly impaired liver function, or heart disease should be monitored closely while taking this medication. While taking this medication, side effects such as dizziness, headache, fatigue, gastrointestinal disorders, skin rash, swelling, and palpitations may occur; thus, patients should consult with healthcare professionals immediately if any unusual symptoms arise. Patients with liver or kidney problems should consult with their physician before taking this medication and have regular liver and kidney function tests. This medication may interact with other antihypertensive medications, diuretics, potassium supplements, and some diabetes medications, so it is essential to inform about all other medications being taken. Pregnant or breastfeeding women should not take this medication, and breastfeeding should either be stopped or discussed with a physician while on this medication. Children or elderly patients over 75 years of age should use this medication cautiously as its safety and efficacy have not been fully established, and especially in the elderly, starting with a lower dose is advisable. In case of overdose, there may be a significant drop in blood pressure or irregular heartbeats, and immediate emergency treatment should be sought if any abnormal symptoms occur. This medication should be stored out of reach of children, and it is important to avoid transferring it to other containers to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, at room temperature between 1 to 30 degrees Celsius. Additionally, it should be kept in a dark place to protect it from light exposure.
Pink oval film-coated tablets
Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationIrbesartan 150mg · Amlodipine Besylate 14mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationIrbesartan 150mg · Amlodipine Besylate 7mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationIrbesartan 300mg · Amlodipine Besylate 7mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.